Cabergoline News and Research

RSS
Researchers identify mechanism that explains why women experience more pain than men

Researchers identify mechanism that explains why women experience more pain than men

Eisai, Arena complete two Phase 1 registrational trials for once-daily formulation of lorcaserin

Eisai, Arena complete two Phase 1 registrational trials for once-daily formulation of lorcaserin

New study finds link between conflict and reinforcement learning

New study finds link between conflict and reinforcement learning

Mylan Pharmaceuticals introduces Cabergoline Tablets USP, 0.5 mg

Mylan Pharmaceuticals introduces Cabergoline Tablets USP, 0.5 mg

Drugs often fail to bring acromegaly under control in routine clinical practice

Drugs often fail to bring acromegaly under control in routine clinical practice

Eisai submits BELVIQ NDS with Health Canada

Eisai submits BELVIQ NDS with Health Canada

Scientists identify TR4 protein that drives the formation of pituitary tumors in Cushing's disease

Scientists identify TR4 protein that drives the formation of pituitary tumors in Cushing's disease

New guidelines for the treatment of acromegaly, a serious growth hormone disorder

New guidelines for the treatment of acromegaly, a serious growth hormone disorder

Patients with advanced Parkinson's disease prefer dopamine agonists, shows review

Patients with advanced Parkinson's disease prefer dopamine agonists, shows review

Watson Pharmaceuticals obtains FTC approval to acquire Arrow Group

Watson Pharmaceuticals obtains FTC approval to acquire Arrow Group

Impax Laboratories acquires ANDA from Watson Pharmaceuticals and Cobalt Laboratories

Impax Laboratories acquires ANDA from Watson Pharmaceuticals and Cobalt Laboratories

Hormone disorder drug cabergoline could help drinkers stay sober

Hormone disorder drug cabergoline could help drinkers stay sober

Approval of generic Dostinex

Approval of generic Dostinex